Sorafenib-d 4

Overview

Sorafenib-d 4 (Bay 43-9006-d 4 ) is the deuterium labeled Sorafenib. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf , and VEGFR-3 , respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Raf | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > FLT3 | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-10201S1
• CAS No.: 1207560-07-3
• Molecular Formula: C21H12D4ClF3N4O3
• Molecular Weight: 468.85
• Purity: 99.9%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source